エピジェネティクスの世界市場：修飾酵素、DNAポリメラーゼ、アセチラーゼ、メチルトランスフェラーゼ、機器、消耗品、キット、試薬...市場調査レポートについてご紹介

1 Introduction (Page No. – 11)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope of Epigenetics
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 13)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 20)

4 Premium Insights (Page No. – 23)
4.1 Global Epigenetics Market Overview
4.2 Life Cycle Analysis for Epigenetics, By Region

5 Market Overview (Page No. – 26)
5.1 Introduction
5.2 Market Segmentation of Epigenetics
5.2.1 Epigenetics Market Segmentation: By Product
5.2.2 Epigenetics Market Segmentation: By Research Area
5.3 Market Dynamics of Epigenetics
5.3.1 Drivers
5.3.1.1 High Prevalence of Cancer
5.3.1.2 Growing Funding for Epigenetics-Based Research
5.3.1.3 Increasing Intensity of Research Activities in the Field of Epigenetics
5.3.1.4 Growing Application of Epigenetics in Non-Oncology Diseases
5.3.1.5 Growth in the Number of Partnerships Between Academic Institutes and Biotechnology & Pharmaceutical Companies for Epigenetic-Based Products
5.3.2 Restraints
5.3.2.1 High Cost of Instruments
5.3.2.2 Lack of Trained Professionals
5.3.3 Opportunities
5.3.3.1 Emerging Markets to Present Significant Growth Opportunities

6 Epigenetics Market, By Product (Page No. – 32)
6.1 Introduction
6.2 Enzymes
6.2.1 DNA-Modifying Enzymes
6.2.2 Protein-Modifying Enzymes
6.2.3 Rna-Modifying Enzymes
6.3 Instruments and Consumables
6.3.1 Mass Spectrometers
6.3.2 Next-Generation Sequencers
6.3.3 QPCR
6.3.4 Sonicators
6.3.5 Other Epigenetics Instruments and Consumables
6.4 KITS
6.4.1 Bisulfite Conversion KITS
6.4.2 Chip-Seq KITS
6.4.3 Rna Sequencing KITS
6.4.4 Whole-Genome Amplification KITS
6.4.5 5-HMC and 5-MC Analysis KITS
6.4.6 Other Epigenetics KITS
6.5 Reagents
6.5.1 Antibodies
6.5.2 Buffers
6.5.3 Histones
6.5.4 Magnetic Beads
6.5.5 Primers
6.5.6 Other Epigenetics Reagents

7 Epigenetics Market, By Research Area (Page No. – 60)
7.1 Introduction
7.2 Developmental Biology
7.3 Drug Discovery
7.4 Oncology
7.5 Other Research Areas

8 Epigenetics Market, By Region (Page No. – 69)
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.4 Asia
8.5 Rest of the World (ROW)

9 Competitive Landscape (Page No. – 104)
9.1 Introduction
9.2 Strategic Overview
9.3 Leading Players in the Epigenetics Market
9.4 Competitive Situation and Trends of Epigenetics
9.4.1 New Product and Service Launches
9.4.2 Agreements, Alliances, Collaborations, and Partnerships
9.4.3 Acquisitions
9.4.4 Expansions
9.4.5 Other Developments

10 Company Profiles (Page No. – 114)
10.1 Introduction
10.2 Abcam PLC
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Recent Developments
10.2.4 MnM View
10.2.4.1 Financial Analysis
10.2.4.2 Strategic Analysis
10.3 Active Motif
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Recent Developments
10.3.4 MnM View
10.3.4.1 Strategic Analysis
10.4 Diagenode, Inc.
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Recent Developments
10.4.4 MnM View
10.4.4.1 Strategic Analysis
10.5 Illumina, Inc.
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Recent Developments
10.5.4 MnM View
10.5.4.1 Financial Analysis
10.5.4.2 Strategic Analysis
10.6 Merck & Co., Inc.
10.6.1 Business Overview
10.6.2 Products Offered
10.6.3 Recent Developments
10.6.4 MnM View
10.6.4.1 Financial Analysis
10.6.4.2 Strategic Analysis
10.7 New England Biolabs
10.7.1 Business Overview
10.7.2 Products Offered
10.7.3 Recent Developments
10.7.4 MnM View
10.7.4.1 Strategic Analysis
10.8 Qiagen N.V.
10.8.1 Business Overview
10.8.2 Products Offered
10.8.3 Recent Developments
10.8.4 MnM View
10.8.4.1 Financial Analysis
10.8.4.2 Strategic Analysis
10.9 Sigma-Aldrich Corporation
10.9.1 Business Overview
10.9.2 Products Offered
10.9.3 Recent Developments
10.9.4 MnM View
10.9.4.1 Financial Analysis
10.9.4.2 Strategic Analysis
10.10 Thermo Fisher Scientific, Inc.
10.10.1 Business Overview
10.10.2 Products Offered
10.10.3 Recent Developments
10.10.4 MnM View
10.10.4.1 Financial Analysis
10.10.4.2 Strategic Analysis
10.11 Zymo Research Corporation
10.11.1 Business Overview
10.11.2 Products Offered
10.11.3 Recent Developments
10.11.4 MnM View
10.11.4.1 Strategic Analysis

11 Appendix (Page No. – 148)
11.1 Insights of Industry Experts
11.2 Discussion Guide
11.3 Other Developments in Epigenetics
11.4 Introducing RT: Real-Time Market Intelligence
11.5 Available Customizations
11.6 Related Reports